ReviewPharmaceuticals (Basel, Switzerland)2024

Advancing Chimeric Antigen Receptor T-Cell Therapy for Acute Myeloid Leukemia: Current Limitations and Emerging Strategies.

Daniela Damiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.